ArticleTranslational psychiatry2025
Exploring the capabilities of repetitive transcranial magnetic stimulation in major depressive disorder: Dynamic causal modeling of the neural network.
Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prefrontal Transcranial Pulse Stimulation for Major Depressive Disorder: A Randomized Clinical Trial.JAMA network open · 2026Trial
- Post-Stroke Depression Is Associated With Shared Neurodevelopmental Risk and Circuit Disruption.Brain and behavior · 2026Article
- Comparing local brain activity and distant functional connectivity in transgender women compared to cisgender controls.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Repetitive transcranial magnetic stimulation (rTMS) of the left dorsal prefrontal cortex (DLPFC) has been utilized to manage treatment-resistant major depressive disorder (MDD). Understanding the biological basis of rTMS treatment in MDD is crucial for enhancing its clinical efficacy. Numerous brain regions functionally connected to the left DLPFC have been identified as a critical role in the pathophysiology of MDD, highlighting the significance of alterations in these neural circuits. We employed a dynamic causal modeling to estimate the causal relationships among depression-related regions functionally linked to the left DLPFC using a large-sample, multi-site resting-state functional magnetic resonance imaging dataset, comprising 270 healthy controls and 175 patients with MDD. We revealed aberrant causal connections from the left DLPFC, amygdala (AMY), nucleus accumbens (NAC), and thalamus (Thal) to the visual cortex (VIS) in MDD. We also found negative associations between depression severities and NAC-to-VIS connections, indicating that VIS plays an essential role in MDD. Furthermore, we identified aberrant causal connections between the ventromedial prefrontal cortex (VMPFC) and subcortical regions including, AMY, NAC, and subgenual anterior cingulate cortex (sgACC), and positive correlation between the depression severities and AMY-to-sgACC connection, suggesting the disruption in corticostriatal circuit is related to the aberrant emotional regulation in MDD. These aberrant connections may support the neural mechanisms of MDD and indicate rTMS may modulate these areas, potentially improving the disrupted function in MDD. Our study provides deeper insights into the pathophysiological mechanisms of MDD and the potential mechanisms of rTMS treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.